RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 33 filers reported holding RENEO PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $942,128 | +116.0% | 123,720 | +86.1% | 0.01% | +133.3% |
Q2 2023 | $436,155 | +36.5% | 66,487 | +24.4% | 0.01% | +20.0% |
Q1 2023 | $319,499 | +403.5% | 53,428 | +96.2% | 0.01% | +400.0% |
Q4 2022 | $63,451 | -70.1% | 27,232 | -56.9% | 0.00% | -75.0% |
Q3 2022 | $212,000 | – | 63,210 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverVest Venture Management LLC | 2,409,220 | $8,071,000 | 9.37% |
Abingworth LLP | 2,073,957 | $6,948,000 | 2.38% |
Aisling Capital Management LP | 886,075 | $2,968,000 | 1.97% |
NEA Management Company, LLC | 4,786,921 | $16,036,000 | 0.80% |
Novo Holdings A/S | 3,430,377 | $11,492,000 | 0.55% |
Ikarian Capital, LLC | 155,819 | $521,000 | 0.10% |
Rock Springs Capital Management LP | 1,143,185 | $3,830,000 | 0.10% |
Ergoteles LLC | 37,640 | $126,000 | 0.00% |
MAI Capital Management | 63,210 | $212,000 | 0.00% |
RBF Capital, LLC | 14,536 | $49,000 | 0.00% |